Le Lézard
Classified in: Science and technology
Subject: Philanthropy

NBCC's Going Beyond campaign to transform New Brunswick's workforce


SAINT JOHN, New Brunswick, June 02, 2022 (GLOBE NEWSWIRE) -- NBCC set forth its vision to transform New Brunswick's workforce with the launch of its first-ever fundraising campaign, Going Beyond, today.

In an event held at the College's Trades Education Centre in Saint John, NBCC President and CEO Mary Butler unveiled a bold plan to respond to what she called New Brunswick's "critical moment."

"With a third of our labour force set to retire in the next few years, automation disrupting our existing jobs, and the lowest percentage of post-secondary attainment among the provinces, we need to do more," said Butler. "With a proven track record of fueling New Brunswick's workforce, we are ready to take on this challenge."

The $16-million campaign charts a course for NBCC to:

"We're asking our industry and community partners to join us in being catalysts for this transformative change in post-secondary education," said Butler.

The Going Beyond campaign is chaired by James D. Irving, co-CEO of J.D. Irving, Limited, who called upon his fellow industry leaders to support NBCC's vision.

"Keeping and growing talented young people here at home in New Brunswick with valued skills and expertise is important," says Irving.?"NBCC is foundational in developing young New Brunswickers. We are happy to step up and kick-start the private sector fundraising for this important institution in the province."

Irving's commitment, along with J.D. Irving, Limited's gift of $1 million, inspired early fundraising success, with $12.9 million already committed. NBCC will announce other donors over the coming weeks and months.

MEDIA CONTACT:
Tanya Greer, Lead, Strategic Communications, NBCC
506.440.9105, [email protected]



These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: